Synthesis of influenza neuraminidase inhibitors

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 6, 2001, Pages 776-791

  Abdel Magid, A F ^a   Maryanoff, C A ^a   Mehrman, S J ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Influenza neuraminidase inhibitors; Neuraminidase inhibitors; Oseltamivir phosphate; Relenza ; RWJ 270201; Tamiflu ; Zanamivir

Indexed keywords

2 DEOXY 2,3 DIDEHYDRO N TRIFLUOROACETYLNEURAMINIC ACID; 4 ACETAMIDO 3 GUANIDINOBENZOIC ACID; 4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 4 ACETYLAMINO 3 (IMIDAZOL 1 YL)BENZOIC ACID DERIVATIVE; A 192558; AMANTADINE; BANA 206; BENZOIC ACID DERIVATIVE; N ACETYL 2,3 DIDEHYDRO 2 DEOXYNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE; OSELTAMIVIR; PERAMIVIR; QUINIC ACID; RIMANTADINE; SHIKIMIC ACID; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

CYCLIZATION; DISEASE COURSE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PROCESS CONTROL; REVIEW;

ANTIVIRAL AGENTS; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; ORTHOMYXOVIRIDAE;

EID: 0035179954     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Preparing for battle
2. Disarming flu viruses
3. The origin and control of pandemic influenza
4. Rational design of potent sialidase-based inhibitors of influenza virus replication
5. Design and synthesis of influenza virus sialidase inhibitors: Novel anti-influenza drugs
6. Crystallization and peptide maps of neuraminidase 'heads' from H2N2 and H2N3 influenza virus strains
7. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution
8. Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus
9. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis
10. Structure of influenza virus neuraminidase B/Leet/4O complexed with sialic acid and a dehydro analog at 1.8-Å resolution: Implications for the catalytic mechanism
11. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase
12. 2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids
13. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
14. Development of neuraminidase inhibitors as anti-influenza virus drugs
15. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: A potent influenza virus sialidase inhibitor
16. Synthesis of the potent influenza neuraminidase inhibitor 4-guanidino Neu5Ac2en. X-ray molecular structure of 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-D-erythro-L-gluco-nonionic acid
17. A convenient synthesis of guanidines from thioureas
18. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogs with potent anti-influenza activity
19. (-)-Methyl cis-3-hydroxy-4,5-oxycyclohex-1-enecarboxylate: Stereospecific formation from and conversion to (-)-methyl shikimate; complex formation with bis(carbomethoxy)hydrazine
20. Practical total synthesis of the anti-influenza drug GS-4104
21. Industrial synthesis of the key precursor in the synthesis of the anti-influenza drug oseltamivir phosphate (Ro 64-0796/002, GS-4104-02): Ethyl (3R,4S,5S)-4,5-epoxy-3-(1-ethyl-propoxy)-1-cyclohex-1-ene-1-carboxylate
22. New azide-free transformation of epoxides into 1,2-diamino compounds: Synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu)
23. BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structurebased drug design
24. Design, synthesis, structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores
25. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design
26. Synthesis and influenza neuraminidase inhibitory activity of aromatic analogs of sialic acid
27. Benzoic acid inhibitors of influenza virus neuraminidase
28. Structures of aromatic inhibitors of influenza virus neuraminidase
29. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction
30. Hydrophobic benzoic acids as inhibitors of influenza neuraminidase
31. Design of aromatic inhibitors of influenza virus neuraminidase
32. Design of aromatic inhibitors of influenza virus neuraminidase
33. Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes
34. Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping
35. A strategy for theoretical binding constant, K, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase
36. 4-Acetylamino-3-(imidazol-1-yl)-benzoic acids as novel inhibitors of influenza sialidase
37. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site
38. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent
39. The origin and control of pandemic influenza